» Articles » PMID: 35448246

3D Printing in Solid Dosage Forms and Organ-on-Chip Applications

Overview
Specialty Biotechnology
Date 2022 Apr 21
PMID 35448246
Authors
Affiliations
Soon will be listed here.
Abstract

3D printing (3DP) can serve not only as an excellent platform for producing solid dosage forms tailored to individualized dosing regimens but can also be used as a tool for creating a suitable 3D model for drug screening, sensing, testing and organ-on-chip applications. Several new technologies have been developed to convert the conventional dosing regimen into personalized medicine for the past decade. With the approval of Spritam, the first pharmaceutical formulation produced by 3DP technology, this technology has caught the attention of pharmaceutical researchers worldwide. Consistent efforts are being made to improvise the process and mitigate other shortcomings such as restricted excipient choice, time constraints, industrial production constraints, and overall cost. The objective of this review is to provide an overview of the 3DP process, its types, types of material used, and the pros and cons of each technique in the application of not only creating solid dosage forms but also producing a 3D model for sensing, testing, and screening of the substances. The application of producing a model for the biosensing and screening of drugs besides the creation of the drug itself, offers a complete loop of application for 3DP in pharmaceutics.

Citing Articles

3D Bioprinting in Cancer Modeling and Biomedicine: From Print Categories to Biological Applications.

Yang J, Wang L, Wu R, He Y, Zhao Y, Wang W ACS Omega. 2024; 9(44):44076-44100.

PMID: 39524656 PMC: 11541486. DOI: 10.1021/acsomega.4c06051.


Development of a Bladder Cancer-on-a-Chip Model to Assess Bladder Cancer Cell Invasiveness.

Ewell D, Vue N, Moinuddin S, Sarkar T, Ahsan F, Vinall R Cancers (Basel). 2024; 16(15).

PMID: 39123388 PMC: 11311651. DOI: 10.3390/cancers16152657.


The synergy of nucleic acid amplification and miniaturized systems in enhancing liquid biopsy applications.

Nguyen N, Van T, Nguyen T Bioanalysis. 2024; 16(11):499-504.

PMID: 38380670 PMC: 11299790. DOI: 10.4155/bio-2023-0238.


Biomedical Applications of Microfluidic Devices: A Review.

Gharib G, Butun I, Muganli Z, Kozalak G, Namli I, Seyedmirzaei Sarraf S Biosensors (Basel). 2022; 12(11).

PMID: 36421141 PMC: 9688231. DOI: 10.3390/bios12111023.


Multilayer Soft Photolithography Fabrication of Microfluidic Devices Using a Custom-Built Wafer-Scale PDMS Slab Aligner and Cost-Efficient Equipment.

Nguyen T, Sarkar T, Tran T, Moinuddin S, Saha D, Ahsan F Micromachines (Basel). 2022; 13(8).

PMID: 36014279 PMC: 9412704. DOI: 10.3390/mi13081357.

References
1.
Lind J, Kalvemark Sporrong S, Kaae S, Rantanen J, Genina N . Social aspects in additive manufacturing of pharmaceutical products. Expert Opin Drug Deliv. 2016; 14(8):927-936. DOI: 10.1080/17425247.2017.1266336. View

2.
Li Q, Wen H, Jia D, Guan X, Pan H, Yang Y . Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Int J Pharm. 2017; 525(1):5-11. DOI: 10.1016/j.ijpharm.2017.03.066. View

3.
Goyanes A, Buanz A, Hatton G, Gaisford S, Basit A . 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2014; 89:157-62. DOI: 10.1016/j.ejpb.2014.12.003. View

4.
Pietrzak K, Isreb A, Alhnan M . A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 2015; 96:380-7. DOI: 10.1016/j.ejpb.2015.07.027. View

5.
Yi H, Choi Y, Kang K, Hong J, Pati R, Park M . A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release. 2016; 238:231-241. DOI: 10.1016/j.jconrel.2016.06.015. View